Cardiovascular

Cardiovascular disease

including

heart disease

andstroke

is a major global health concern and the leading cause of death and disability worldwide¹

Mode of Action of Idarucizumab
(Praxbind®)

Document ID: MPR-PH-100003

01/06/2018

Author: Boehringer Ingelheim

Dabigatran inhibits the formation of blood clots by specifically binding to thrombin

123,000
Views

100k 340

Production date: May 2019